Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine

被引:3
作者
Mei, Liyan [1 ]
Gao, Kaixin [1 ]
He, Xiaojuan [2 ]
Jakobsson, Per-Johan [3 ]
Huang, Runyue [1 ,4 ,5 ,6 ]
机构
[1] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China
[2] China Acad Chinese Med Sci, Beijing, Peoples R China
[3] Karolinska Inst KI, Solna, Sweden
[4] Guangzhou Univ Chinese Med, Guangdong Hong Kong Macau Joint Lab Chinese Med &, Hong Kong, Guangdong, Peoples R China
[5] Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China
[6] Guangdong Prov Key Lab Clin Res Tradit Chinese Med, Guangzhou, Peoples R China
关键词
disease-modifying antirheumatic drugs (DMARDs); traditional Chinese medicine (TCM); DMARDs-like effects; rheumatic diseases; new strategies; RHEUMATOID-ARTHRITIS; SAFETY;
D O I
10.3389/fphar.2023.1135803
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
[21]   The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis [J].
Ozen, Gulsen ;
Pedro, Sofia ;
Michaud, Kaleb .
JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) :648-655
[22]   The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation [J].
Goralczyk, Alicja ;
Kolossa, Katarzyna ;
Waszczak-Jeka, Marzena ;
Adamczak, Rafal ;
Jeka, Slawomir .
POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (03) :306-312
[23]   German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs [J].
Katinka Albrecht ;
Klaus Krüger ;
Jürgen Wollenhaupt ;
Rieke Alten ;
Marina Backhaus ;
Christoph Baerwald ;
Wolfgang Bolten ;
Jürgen Braun ;
Harald Burkhardt ;
Gerd R. Burmester ;
Markus Gaubitz ;
Angela Gause ;
Erika Gromnica-Ihle ;
Herbert Kellner ;
Jens Kuipers ;
Andreas Krause ;
Hans-Martin Lorenz ;
Bernhard Manger ;
Hubert Nüßlein ;
Hans-Georg Pott ;
Andrea Rubbert-Roth ;
Matthias Schneider ;
Christof Specker ;
Hendrik Schulze-Koops ;
Hans-Peter Tony ;
Siegfried Wassenberg ;
Ulf Müller-Ladner .
Rheumatology International, 2014, 34 :1-9
[24]   German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs [J].
Albrecht, Katinka t ;
Krueger, Klaus ;
Wollenhaupt, Juergen ;
Alten, Rieke ;
Backhaus, Marina ;
Baerwald, Christoph ;
Bolten, Wolfgang ;
Braun, Juergen ;
Burkhardt, Harald ;
Burmester, Gerd R. ;
Gaubitz, Markus ;
Gause, Angela ;
Gromnica-Ihle, Erika ;
Kellner, Herbert ;
Kuipers, Jens ;
Krause, Andreas ;
Lorenz, Hans-Martin ;
Manger, Bernhard ;
Nuesslein, Hubert ;
Pott, Hans-Georg ;
Rubbert-Roth, Andrea ;
Schneider, Matthias ;
Specker, Christof ;
Schulze-Koops, Hendrik ;
Tony, Hans-Peter ;
Wassenberg, Siegfried ;
Mueller-Ladner, Ulf .
RHEUMATOLOGY INTERNATIONAL, 2014, 34 (01) :1-9
[25]   The Relationship Between Autoimmune Disease and Disease-Modifying Antirheumatic Drugs on Wound Healing [J].
Kirloskar, Kunal M. ;
Dekker, Paige K. ;
Kiene, Julianne ;
Zhou, Suzanne ;
Bekeny, Jenna C. ;
Rogers, Ashley ;
Zolper, Elizabeth G. ;
Fan, Kenneth L. ;
Evans, Karen K. ;
Benedict, Carol Deane ;
Pasieka, Helena B. ;
Attinger, Christopher E. .
ADVANCES IN WOUND CARE, 2022, 11 (12) :650-656
[26]   Inconsistent Treatment with Disease-modifying Antirheumatic Drugs: A Longitudinal Data Analysis [J].
Mjaavatten, Maria D. ;
Radner, Helga ;
Yoshida, Kazuki ;
Shadick, Nancy A. ;
Frits, Michelle L. ;
Iannaccone, Christine K. ;
Kvien, Tore K. ;
Weinblatt, Michael E. ;
Solomon, Daniel H. .
JOURNAL OF RHEUMATOLOGY, 2014, 41 (12) :2370-2378
[27]   Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma [J].
Calip, Gregory S. ;
Patel, Pritesh R. ;
Sweiss, Karen ;
Wu, Zhaoju ;
Zhou, Jifang ;
Asfaw, Alemseged A. ;
Adimadhyam, Sruthi ;
Lee, Todd A. ;
Chiu, Brian C-H .
INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (05) :1300-1305
[28]   Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients [J].
Mittal, Niti ;
Mittal, Rakesh ;
Sharma, Aman ;
Jose, Vinu ;
Wanchu, Ajay ;
Singh, Surjit .
SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) :532-536
[29]   Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis [J].
Kemper, Alex R. ;
Van Mater, Heather A. ;
Coeytaux, Remy R. ;
Williams, John W., Jr. ;
Sanders, Gillian D. .
BMC PEDIATRICS, 2012, 12
[30]   Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [J].
Terabe, Kenya ;
Takahashi, Nobunori ;
Asai, Shuji ;
Hirano, Yuji ;
Kanayama, Yasuhide ;
Yabe, Yuichiro ;
Oguchi, Takeshi ;
Fujibayashi, Takayoshi ;
Ishikawa, Hisato ;
Hanabayashi, Masahiro ;
Hattori, Yosuke ;
Suzuki, Mochihito ;
Kishimoto, Kenji ;
Ohashi, Yoshifumi ;
Imaizumi, Takahiro ;
Imagama, Shiro ;
Kojima, Toshihisa .
MODERN RHEUMATOLOGY, 2023, 33 (02) :292-301